Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

The Two-State Receptor Model

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

Drug-Receptor Interactions

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

How Positive Psychology Can Augment Leadership Through the Therapeutic Alliance.

MedEdPORTAL : the journal of teaching and learning resources·2025

Same author

3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist.

Neuropharmacology·2015

Same author

3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activity.

European journal of medicinal chemistry·2015

Same author

Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): histamine H(3) receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity.

Bioorganic & medicinal chemistry letters·2014

Same author

From an atypical wake-promoting agent to potent histamine-3 receptor inverse agonists.

Chemical biology & drug design·2012

Same author

Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists.

Bioorganic & medicinal chemistry letters·2012

Search research articles

Related Experiment Video

Updated: May 25, 2026

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

Practical aspects of radioligand binding.

Michael McKinney¹, Rita Raddatz

¹Mayo Clinic Jacksonville, Jacksonville, Florida, USA.

Current Protocols in Pharmacology

|February 2, 2012

Summary

Radioligand binding assays are essential for identifying receptor binding sites and novel ligands. This review covers assay development, validation, and data interpretation for characterizing ligand-receptor interactions.

Area of Science:

Pharmacology
Biochemistry
Molecular Biology

Background:

Radioligand binding assays have long been utilized for receptor research.
Advancements in receptor preparation and radioligand detection have been made.
Core principles of radioligand binding assays remain consistent.

Purpose of the Study:

To review the theory behind radioligand binding assays.
To provide examples for calculating parameters of ligand-receptor interactions.
To discuss assay development, validation, and component selection.

Main Methods:

Review of established radioligand binding assay principles.
Discussion of parameters derived from binding data.
Guidance on selecting radioligands, buffers, and assay components.

More Related Videos

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens

Determining Binding Affinity (K_D) of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

Related Experiment Videos

Last Updated: May 25, 2026

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens

Determining Binding Affinity (K_D) of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

Main Results:

Characterization of ligand-receptor interactions through binding data analysis.
Understanding how assay conditions influence binding.
Validation of assay development for meaningful interpretation.

Conclusions:

Radioligand binding assays are crucial for characterizing ligand-receptor interactions.
Careful selection of assay components and conditions is vital for assay success.
Assay validation ensures reliable and interpretable results.